Offer - Urjas Oil for just ₹ 1 X
Rosuvas F 5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. The alternative uses of Rosuvas F 5 Tablet have also been explained below.
The right dosage of Rosuvas F 5 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Rosuvas F 5 Tablet are Nausea or vomiting, Headache, Constipation. While these are the most often observed Rosuvas F 5 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Rosuvas F 5 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Rosuvas F 5 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Rosuvas F 5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rosuvas F 5 Tablet related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Rosuvas F 5 Tablet since this can cause severe adverse effects.
Besides this, Rosuvas F 5 Tablet may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Rosuvas F 5 Tablet is not safe while driving, and is not addiction.
Rosuvas F 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rosuvas F 5 Tablet safe for pregnant women?
Rosuvas F may have some side effects during pregnancy. Pregnant women should discontinue the use of Rosuvas F, and talk to their doctor, if they notice any discomfort.
Is the use of Rosuvas F 5 Tablet safe during breastfeeding?
Rosuvas F may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Rosuvas F, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Rosuvas F.
What is the effect of Rosuvas F 5 Tablet on the Kidneys?
Rosuvas F may have mild side effects on the kidneys.
What is the effect of Rosuvas F 5 Tablet on the Liver?
Rosuvas F is rarely harmful for the liver.
What is the effect of Rosuvas F 5 Tablet on the Heart?
The heart can be affected by Rosuvas F. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Rosuvas F 5 Tablet unless your doctor advises you to do so -
Is this Rosuvas F 5 Tablet habit forming or addictive?
No, there is no any evidence that Rosuvas F 5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Rosuvas F 5 Tablet as you may feel sleepy.
Is it safe?
Yes, Rosuvas F 5 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Rosuvas F 5 Tablet in mental disorders is not effective.
Interaction between Food and Rosuvas F 5 Tablet
Information is not available on the interaction of any foods with Rosuvas F 5 Tablet, due to a lack of research on this.
Interaction between Alcohol and Rosuvas F 5 Tablet
Due to lack of research, there is no information about the side effects of taking Rosuvas F 5 Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650